Robert C. Speth
Robert C. Speth earned his Ph.D. degree in pharmacology from Vanderbilt University in 1976. He did his postdoctoral training with Hank Yamamura in pharmacology at the University of Arizona College of Medicine (1976–1979). He is a Professor of pharmacology and a former Chair of the School of Pharmacy, University of Mississippi. He is also the Director of the Peptide Radioiodination Service Center which provides large-scale, low-cost radioligands to researchers worldwide. With Dr. Yamamura, he published the first paper describing benzodiazepine binding site in the human brain. His research focuses on the brain angiotensin system and cardiovascular regulation. Included among the 160 papers he published are the first autoradiographic localization of angiotensin receptor subtypes in the brain, identification of angiotensin II analogs with receptor subtype specificity, the discovery of angiotensin receptors in the male and female reproductive systems, identification of the mas oncogene protein as the receptor for angiotensin 1–7, and the recent discovery of a novel non-AT1, non-AT2 binding site for angiotensins in the brain. Dr. Speth is also recognized for his work in biomedical research ethics. He was a Charter Member of the Ethics Committee of the Endocrine Society, a Charter Officer, past President, and a Founding Editor of the Newsletter of the Society for Veterinary Medical Ethics. He published numerous articles supporting the use of animals in biomedical research and appeared on radio and television to advocate the responsible use of animals in biomedical research. He is a Member of the Board of Directors of the National Animal Interest Alliance and an Emeritus Board Member of the Washington Association for Biomedical Research. He is also a Fellow of the American Association for the Advancement of Science and a Member of the Editorial Board of the Regulatory Peptides.
Biography Updated on 29 September 2008